SynthesisFrontiers in immunology2026

Neoadjuvant chemoradiotherapy with or without PD-1 inhibitors in MMR-proficient non-metastatic rectal cancer: a meta-analysis of randomized controlled trials.

Yuegang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.